Valuemedics Research LLC is categorized under Wholesale Pharmaceutical Products in Seattle, WA and active since 2004.
Valuemedics Research LLC was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Georgette Semroc at the company’s single location by writing to 120 North 54th St, Seattle, Washington WA 98103 or by phoning (206) 706-4519. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Valuemedics Research LLC |
| Contact Person: | Georgette Semroc |
| Address: | 120 North 54th St, Seattle, Washington 98103 |
| Phone Number: | (206) 706-4519 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Valuemedics Research LLC was started in 2004 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Georgette Semroc for inquiries that concern Valuemedics Research LLC by calling the company number (206) 706-4519, as your correspondence is most welcome. Additionally, the physical location of the single location of Valuemedics Research LLC can be found at the coordinates 47.668069,-122.356629 as well as the street address 120 North 54th St in Seattle, Washington 98103.
For its online presence, you may visit Valuemedics Research LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.